The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Palmeux 100 mg prolonged-release suspension for injection in pre-filled syringe

Amdipharm LimitedPA1142/040/004

Main Information

Trade NamePalmeux 100 mg prolonged-release suspension for injection in pre-filled syringe
Active SubstancesPaliperidone palmitate
Dosage FormProlonged-release suspension for injection in pre-filled syringe
Licence HolderAmdipharm Limited
Licence NumberPA1142/040/004

Group Information

ATC CodeN05AX13 paliperidone


License statusAuthorised
Licence Issued04/03/2022
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0130-024-064
Interchangeable List DocumentPDF of Interchangeable List
« Back